Table 3.
Variables | Category | Frequency | Percent | |
---|---|---|---|---|
Duration of therapy (years) | <5 | 125 | 42.1 | |
5 – 10 | 101 | 34 | ||
≥10 | 71 | 23.9 | ||
Medications | Monotherapy (n=147) |
Enalapril | 113 | 38.0 |
Hydrochlorothiazide | 23 | 7.7 | ||
Nifedepine | 11 | 3.7 | ||
Drug Combination (n=150) |
Hydrochlorothiazide+ Enalapril | 109 | 36.7 | |
Hydrochlorothiazide+ Nifedepine | 2 | 0.7 | ||
Hydrochlorothiazide+ Propranolol | 1 | 0.3 | ||
Enalapril + Nifedepine | 33 | 11.1 | ||
Enalapril + Atenolol | 4 | 1.3 | ||
Enalapril + Propranolol | 1 | 0.3 | ||
Source of medication | Self-sponsored | 131 | 44.1 | |
Free of charge | 123 | 41.4 | ||
By sponsorship | 43 | 14.5 | ||
Side effect | Yes | 91 | 30.6 | |
No | 206 | 69.4 | ||
Experienced Side effect (n=91) |
Weakness | 34 | 37.36 | |
Headache | 24 | 26.37 | ||
Dry mouth | 14 | 15.38 | ||
Erectile dysfunction | 8 | 8.79 | ||
GI complaint | 3 | 3.3 | ||
Cough | 3 | 3.3 | ||
Others* | 4 | 4.4 |
Notes: *Others: Postural hypertension, Edema, Loss of appetite, Foot pain
Abbreviations: GI, gastro-intestinal; NRH, Nekemte Referral Hospital.